EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial
Links shared publicly online about this topic.
- 495total visits
EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial
Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.
View full resource at news-medical.net
Tags: Vaccination, Cancer, Ovarian Cancer, Healthcare, Healthy Living, Women's Health, Vaccine, Biomed
Most Recently Shared on February 19, 2011 at 9:45 am By:
EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial: Australian health car... http://bit.ly/hLzTyY
Buzzup US News -
buzzup.com — “Buzzup is a user driven social content website. Buzzup news and stories are submitted by our community (that would be you).After you submit content, other people read your submission and vote for what they like best, we call this linking” View full resource at buzzup.com
Most Recently Shared on February 19, 2011 at 9:59 am By:
Ovarian Cancer News: EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III tria... http://buzzup.com/1ldp7
Advertisement
